Table 3

Crude and adjusted ORs with associated 95% CIs of NAFLD for cancer stratified by BMI categories in 233 patients with T2DM

VariablesCrude ORAdjusted OR†
OR95% CIP valueOR95% CIP value
Underweight or normal weight (BMI <23.0 kg/m2)
 NAFLD (yes vs no)15.7502.184 to 113.5560.006*17.4461.690 to 180.0950.016*
 FIB-4 score1.0240.193 to 5.4260.9780.6000.065 to 5.5160.652
Overweight (BMI 23.0–24.9 kg/m2)
 NAFLD (yes vs no)8.6670.960 to 78.2680.05411.6420.832 to 162.9630.068
 FIB-4 score1.0870.364 to 3.2450.8821.3690.268 to 7.0070.706
Obesity (BMI ≥25.0 kg/m2)
 NAFLD (yes vs no)1.5320.326 to 7.1970.5890.9170.170 to 4.9540.920
 FIB-4 score1.2970.574 to 2.9310.5310.9850.347 to 2.7910.977
  • *P<0.05.

  • †Adjusted for sex, age, ever smoking, ever drinking, systolic and diastolic blood pressure, triglyceride, total cholesterol, HDL-cholesterol and LDL-cholesterol, HbA1c, serum uric acid, oral hypoglycemic medications and insulin use.

  • BMI, body mass index; FIB-4, fibrosis-4; HbA1c, glycosylated hemoglobin A1c; HDL, high-density lipoprotein; LDL, low-density lipoprotein; NAFLD, non-alcoholic fatty liver disease; T2DM, type 2 diabetes mellitus.